The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay
Of 1,455 unique patients in U.S. intensive care units (ICUs), 4% were rectally colonized with CRE on admission. A total of 297 patients were initially negative for carbapenem-resistant (CRE) and remained in the ICU long enough to contribute additional swabs; 22% of these patients had a subsequent CR...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial agents and chemotherapy 2019-08, Vol.63 (8) |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 8 |
| container_start_page | |
| container_title | Antimicrobial agents and chemotherapy |
| container_volume | 63 |
| creator | Tamma, Pranita D Kazmi, Abida Bergman, Yehudit Goodman, Katherine E Ekunseitan, Ernest Amoah, Joe Simner, Patricia J |
| description | Of 1,455 unique patients in U.S. intensive care units (ICUs), 4% were rectally colonized with CRE on admission. A total of 297 patients were initially negative for carbapenem-resistant
(CRE) and remained in the ICU long enough to contribute additional swabs; 22% of these patients had a subsequent CRE-positive swab, with a median time to CRE colonization of 13 days (interquartile range, 7 to 21 days). Patients colonized with carbapenemase-producing CRE were more likely than those colonized with non-carbapenemase-producing CRE to develop CRE infections during their hospitalizations (36% versus 3%;
< 0.05). |
| doi_str_mv | 10.1128/AAC.00757-19 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6658786</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2231857051</sourcerecordid><originalsourceid>FETCH-LOGICAL-a418t-53a1648c00927c50dffc640190cc224c76a908b798bdef5cc5b40670afbc5cdd3</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS0EotvCjTPKEaSmjJPYcS5Iq6WllVaqBOVsTZzJrktiB9up1H_flC0VHDiNRvPNG817jL3jcMZ5oT6t15szgFrUOW9esBWHRuVSNPIlWwFImVcKqiN2HOMtLL1o4DU7KjkvlairFdvd7Cnb2p802L33Xeb77Avd0eAn63YZZhsMLU7kaMy_UbQxoUvZuUsUfItmKRYNIWVXrieTrHdZN4fD6qWPk004ZN8T3r9hr3ocIr19qifsx8X5zeYy315_vdqstzlWXKVclMhlpQxAU9RGQNf3RlbAGzCmKCpTS2xAtXWj2o56YYxoK5A1YN8aYbquPGGfD7rT3I7UGXIp4KCnYEcM99qj1f9OnN3rnb_TUgpVK7kIfHgSCP7XTDHp0UZDw4CO_Bx1UZR8sQ4EX9DTA2qCjzFQ_3yGg37MRi_Z6N_ZaN4s-McDjnEs9K2fg1uc-B_7_u83noX_BFc-AKMfmHU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2231857051</pqid></control><display><type>article</type><title>The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Tamma, Pranita D ; Kazmi, Abida ; Bergman, Yehudit ; Goodman, Katherine E ; Ekunseitan, Ernest ; Amoah, Joe ; Simner, Patricia J</creator><creatorcontrib>Tamma, Pranita D ; Kazmi, Abida ; Bergman, Yehudit ; Goodman, Katherine E ; Ekunseitan, Ernest ; Amoah, Joe ; Simner, Patricia J</creatorcontrib><description>Of 1,455 unique patients in U.S. intensive care units (ICUs), 4% were rectally colonized with CRE on admission. A total of 297 patients were initially negative for carbapenem-resistant
(CRE) and remained in the ICU long enough to contribute additional swabs; 22% of these patients had a subsequent CRE-positive swab, with a median time to CRE colonization of 13 days (interquartile range, 7 to 21 days). Patients colonized with carbapenemase-producing CRE were more likely than those colonized with non-carbapenemase-producing CRE to develop CRE infections during their hospitalizations (36% versus 3%;
< 0.05).</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00757-19</identifier><identifier>PMID: 31138574</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Carbapenem-Resistant Enterobacteriaceae ; Carbapenems ; Enterobacteriaceae Infections ; Epidemiology and Surveillance</subject><ispartof>Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8)</ispartof><rights>Copyright © 2019 American Society for Microbiology.</rights><rights>Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a418t-53a1648c00927c50dffc640190cc224c76a908b798bdef5cc5b40670afbc5cdd3</citedby><cites>FETCH-LOGICAL-a418t-53a1648c00927c50dffc640190cc224c76a908b798bdef5cc5b40670afbc5cdd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658786/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658786/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31138574$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tamma, Pranita D</creatorcontrib><creatorcontrib>Kazmi, Abida</creatorcontrib><creatorcontrib>Bergman, Yehudit</creatorcontrib><creatorcontrib>Goodman, Katherine E</creatorcontrib><creatorcontrib>Ekunseitan, Ernest</creatorcontrib><creatorcontrib>Amoah, Joe</creatorcontrib><creatorcontrib>Simner, Patricia J</creatorcontrib><title>The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay</title><title>Antimicrobial agents and chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Of 1,455 unique patients in U.S. intensive care units (ICUs), 4% were rectally colonized with CRE on admission. A total of 297 patients were initially negative for carbapenem-resistant
(CRE) and remained in the ICU long enough to contribute additional swabs; 22% of these patients had a subsequent CRE-positive swab, with a median time to CRE colonization of 13 days (interquartile range, 7 to 21 days). Patients colonized with carbapenemase-producing CRE were more likely than those colonized with non-carbapenemase-producing CRE to develop CRE infections during their hospitalizations (36% versus 3%;
< 0.05).</description><subject>Carbapenem-Resistant Enterobacteriaceae</subject><subject>Carbapenems</subject><subject>Enterobacteriaceae Infections</subject><subject>Epidemiology and Surveillance</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kUFv1DAQhS0EotvCjTPKEaSmjJPYcS5Iq6WllVaqBOVsTZzJrktiB9up1H_flC0VHDiNRvPNG817jL3jcMZ5oT6t15szgFrUOW9esBWHRuVSNPIlWwFImVcKqiN2HOMtLL1o4DU7KjkvlairFdvd7Cnb2p802L33Xeb77Avd0eAn63YZZhsMLU7kaMy_UbQxoUvZuUsUfItmKRYNIWVXrieTrHdZN4fD6qWPk004ZN8T3r9hr3ocIr19qifsx8X5zeYy315_vdqstzlWXKVclMhlpQxAU9RGQNf3RlbAGzCmKCpTS2xAtXWj2o56YYxoK5A1YN8aYbquPGGfD7rT3I7UGXIp4KCnYEcM99qj1f9OnN3rnb_TUgpVK7kIfHgSCP7XTDHp0UZDw4CO_Bx1UZR8sQ4EX9DTA2qCjzFQ_3yGg37MRi_Z6N_ZaN4s-McDjnEs9K2fg1uc-B_7_u83noX_BFc-AKMfmHU</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Tamma, Pranita D</creator><creator>Kazmi, Abida</creator><creator>Bergman, Yehudit</creator><creator>Goodman, Katherine E</creator><creator>Ekunseitan, Ernest</creator><creator>Amoah, Joe</creator><creator>Simner, Patricia J</creator><general>American Society for Microbiology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190801</creationdate><title>The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay</title><author>Tamma, Pranita D ; Kazmi, Abida ; Bergman, Yehudit ; Goodman, Katherine E ; Ekunseitan, Ernest ; Amoah, Joe ; Simner, Patricia J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a418t-53a1648c00927c50dffc640190cc224c76a908b798bdef5cc5b40670afbc5cdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Carbapenem-Resistant Enterobacteriaceae</topic><topic>Carbapenems</topic><topic>Enterobacteriaceae Infections</topic><topic>Epidemiology and Surveillance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tamma, Pranita D</creatorcontrib><creatorcontrib>Kazmi, Abida</creatorcontrib><creatorcontrib>Bergman, Yehudit</creatorcontrib><creatorcontrib>Goodman, Katherine E</creatorcontrib><creatorcontrib>Ekunseitan, Ernest</creatorcontrib><creatorcontrib>Amoah, Joe</creatorcontrib><creatorcontrib>Simner, Patricia J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tamma, Pranita D</au><au>Kazmi, Abida</au><au>Bergman, Yehudit</au><au>Goodman, Katherine E</au><au>Ekunseitan, Ernest</au><au>Amoah, Joe</au><au>Simner, Patricia J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>63</volume><issue>8</issue><issn>0066-4804</issn><eissn>1098-6596</eissn><abstract>Of 1,455 unique patients in U.S. intensive care units (ICUs), 4% were rectally colonized with CRE on admission. A total of 297 patients were initially negative for carbapenem-resistant
(CRE) and remained in the ICU long enough to contribute additional swabs; 22% of these patients had a subsequent CRE-positive swab, with a median time to CRE colonization of 13 days (interquartile range, 7 to 21 days). Patients colonized with carbapenemase-producing CRE were more likely than those colonized with non-carbapenemase-producing CRE to develop CRE infections during their hospitalizations (36% versus 3%;
< 0.05).</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>31138574</pmid><doi>10.1128/AAC.00757-19</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8) |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6658786 |
| source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Carbapenem-Resistant Enterobacteriaceae Carbapenems Enterobacteriaceae Infections Epidemiology and Surveillance |
| title | The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T05%3A36%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Likelihood%20of%20Developing%20a%20Carbapenem-Resistant%20Enterobacteriaceae%20Infection%20during%20a%20Hospital%20Stay&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=Tamma,%20Pranita%20D&rft.date=2019-08-01&rft.volume=63&rft.issue=8&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/AAC.00757-19&rft_dat=%3Cproquest_pubme%3E2231857051%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2231857051&rft_id=info:pmid/31138574&rfr_iscdi=true |